Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Medimaging Integrated Solution EV-to-EBIT?
Medimaging Integrated SolutionTPE:6796 +1.79%80 EV-to-EBIT is 303.42 as of Aug. 20, 2026, which is 777% above its 10-year median of 34.58. GuruFocus rates TPE:6796 with a GF Score™ of 80/100 and a GF Value™ of NT$103.99 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 472 Medical Devices & Instruments companies, Medimaging Integrated Solution ranks worse than 97.46% on this metric.
The historical rank and industry rank for Medimaging Integrated Solution's EV-to-EBIT or its related term are showing as below:
TPE:6796'
s EV-to-EBIT Range Over the Past 10 Years
Min: -1779.89 Med: 34.58 Max: 361.36
Current: 303.42
During the past 8 years, the highest EV-to-EBIT of Medimaging Integrated Solution was 361.36. The lowest was -1779.89. And the median was 34.58.
TPE:6796's EV-to-EBIT is ranked worse than 97.46% of 472
companies
in the Medical Devices & Instruments industry
Industry Median: 19.665
vs TPE:6796: 303.42
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Medimaging Integrated Solution's Enterprise Value for the quarter that ended in Mar. 2026 was NT$2,976.1 Mil.
Medimaging Integrated Solution's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$8.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medimaging Integrated Solution EV-to-EBIT Related Terms
Medimaging Integrated Solution EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medimaging Integrated Solution's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medimaging Integrated Solution EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medimaging Integrated Solution's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Medimaging Integrated Solution's EV-to-EBIT falls into.
Medimaging Integrated Solution's current Enterprise Value is NT$2,521.4 Mil.
Medimaging Integrated Solution's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$8.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medimaging Integrated Solution (TPE:6796) has a EV-to-EBIT of 303.42 as of Aug. 20, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Medimaging Integrated Solution and its competitors. This is 777% above median its historical median of 34.58. According to the industry distribution chart, Medimaging Integrated Solution ranks #460 out of 472 companies in the Medical Devices & Instruments industry, placing it in the top 97.5%.
Is Medimaging Integrated Solution's EV-to-EBIT too high?
Medimaging Integrated Solution's current EV-to-EBIT of 303.42 is 777% above median its 10-year median of 34.58. The Medical Devices & Instruments industry median EV-to-EBIT is 19.67. Medimaging Integrated Solution's value of 303.42 is 1442.9% above this industry median. Based on the distribution chart, Medimaging Integrated Solution ranks #460 out of 472 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medimaging Integrated Solution has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medimaging Integrated Solution's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medimaging Integrated Solution ranks #460 out of 472 companies for EV-to-EBIT. This places Medimaging Integrated Solution in the lower half of its industry. The industry median EV-to-EBIT is 19.67. Medimaging Integrated Solution's value of 303.42 is 1442.9% above this benchmark. While the company's 10-year median is 34.58 vs. the industry median of 19.67, Medimaging Integrated Solution has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.67, based on 472 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medimaging Integrated Solution's current EV-to-EBIT of 303.42 is 1442.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Medimaging Integrated Solution and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medimaging Integrated Solution's current EV-to-EBIT is 303.42, which is 777% above median its own 10-year median of 34.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medimaging Integrated Solution stock overvalued right now?
Based on GuruFocus' analysis, Medimaging Integrated Solution (TPE:6796) is currently considered Possible Value Trap. The stock's GF Value™ is NT$103.99, compared to a current price of NT$62.50 — trading 39.9% below its estimated fair value. The current EV-to-EBIT is 303.42, which is 777% above median its 10-year median of 34.58 and 1442.9% above the Medical Devices & Instruments industry median of 19.67. Medimaging Integrated Solution's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Medimaging Integrated Solution (TPE:6796), the current EV-to-EBIT is 303.42 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medimaging Integrated Solution (TPE:6796) Overvalued in 2026?
Based on GuruFocus' analysis, Medimaging Integrated Solution stock appears to be undervalued.
The current stock price of NT$62.50 is trading 39.9% below its estimated GF Value™ of NT$103.99.
GuruFocus considers Medimaging Integrated Solution to be Possible Value Trap.
Key valuation signals for TPE:6796:
EV-to-EBIT: 303.42 (777% above median its 10-year median of 34.58)
GF Value™: NT$103.99 vs. price of NT$62.50 (39.9% below fair value)
Industry Position: 1442.9% above the Medical Devices & Instruments median (#460 of 472)
No single metric tells the full story. See the TPE:6796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medimaging Integrated Solution Inc and its subsidiaries are engaged in the design, manufacturing, and sales of digital medical imaging diagnostic equipment and related products and services. The company is a trusted partner of hospitals, medical schools, and health organizations, providing practitioners with digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes. Its products include Horus Scope, Smart Solutions, Endoscopy, and Micro Camera Modules.
80GF Score
Get the complete analysis for TPE:6796
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6796 has been successfully added to your 
